Chinese Journal of Tissue Engineering Research ›› 2014, Vol. 18 ›› Issue (27): 4310-4317.doi: 10.3969/j.issn.2095-4344.2014.27.009

Previous Articles     Next Articles

Individualized treatment prevents patient-prosthesis mismatch after aortic valve replacement with small aortic annulus

Han Jin-song1, Wang Hui-shan1, Yin Zong-tao1, Wang Ting-ting2, Han Hong-guang1, Song Heng-chang1, Jin Yan1   

  1. 1 Department of Cardiovascular Surgery, 2 Library, General Hospital of Shenyang Military Area Command of Chinese PLA, Shenyang 110016, Liaoning Province, China
  • Online:2014-06-30 Published:2014-06-30
  • Contact: Wang Hui-shan, M.D., Chief physician, Professor, Doctoral supervisor, Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command of Chinese PLA, Shenyang 110016, Liaoning Province, China
  • About author:Han Jin-song, Studying for doctorate, Associate chief physician, Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command of Chinese PLA, Shenyang 110016, Liaoning Province, China

Abstract:

BACKGROUND: It is so difficult to have aortic valve replacement with small aortic annulus. Improper treatment may lead to patients with valvular mismatch phenomenon, and thus make left ventricular outflow tract obstruction, increase transvalvular pressures, cause cardiac hypertrophy secondary to increased left ventricular afterload and even congestive heart failure.
OBJECTIVE: To summarize the treatment strategy for preventing valvular mismatch phenomenon caused by small aortic annulus after aortic valve replacement.
METHODS: Eighty-five patients with small aortic annulus underwent aortic valve replacement surgery.
19 mm SJM Regent valve was applied to the patients with orifice diameter > 17 ≤ 19 mm; to the adult patients with orifice diameter ≤ 17 mm, we performed bovine pericardial patch enlargement of the small aortic annulus and valve replacement using 19 mm SJM Regent valve. For those with orifice diameter > 19 ≤ 21 mm, we selected 21 mm Hancock II ultra biological valve for valve replacement. Effective orifice area index, left ventricular mass index, inter-ventricular septal thickness, left ventricular wall thickness, trans-valvular peak velocity, the pressure difference across the valve and trans-valvular mean pressure were measured through echocardiography. After discharge, patients were followed up in out-patient clinic and evaluated regularly by echocardiography.
RESULTS AND CONCLUSION: There were no early deaths after operation and all cases were cured and discharged. Follow-up time was between 6 months and 3 years. The main complications included low cardiac output syndrome in two cases, reoperation due to bleeding in one case, and ventilator dependence in two cases. No cases occurred in cerebral complications such as cerebral hemorrhage or cerebral thrombosis, and no valvular dysfunction or card flap appeared. There was no bovine pericardium tearing, thrombosis, calcification, tumor-like bulge, infection or immune reactions. A total of 81 cases were followed up and the follow-up rate was 95% (81/85). There were NYHA class grade I in 65 cases, and grade II in 16 cases. Peak velocity across the aortic valve and the mean pressure were significantly decreased, effective orifice area index increased significantly, left ventricular mass index, left ventricular wall thickness and the thickness of the inter-ventricular septum were significantly reduced compared with pre-operation, and no valvular mismatch phenomenon occurred. Compared 21 mm Hancock II ultra biological valve with 21 mm SJM Regent group, the former got a better peak velocity and mean trans-valvular pressure, and better left ventricular remodeling index. Body weight and body surface area were significantly increased in 19 mm Regent valve group after operation. The results suggest that individualized treatment strategies should be taken to prevent the occurrence of postoperative valvular mismatch phenomenon for patients with small aortic annulus.



中国组织工程研究
杂志出版内容重点:肾移植肝移植移植;心脏移植;组织移植;皮肤移植;皮瓣移植;血管移植;器官移植组织工程


全文链接:

Key words: organ transplantation, aortic valve, heart valve prosthesis

CLC Number: